Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00728650 · ClinicalTrials.gov registry record

A Retrospective Review of Malignant Liver Tumors

A clinical trial of Liver Cancer, sponsored by University of Oklahoma.

Completed
Registry status
228
Enrollment target
1
Study location

NCT00728650 is a study of Liver Cancer that has completed, run by University of Oklahoma. The registered enrollment target is 228 participants, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (49% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00728650, a study of Liver Cancer, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
228 participants
Enrollment target
1
Study location

Study Summary

This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatments. Tumor recurrence and survival data will be compared to the published literature to determine the efficacy of current treatment strategies in this patient population.

Conditions Studied

Liver Cancer

Study Locations (1)

Oklahoma

  • The University of Oklahoma College of Medicine, Tulsa - Department of Surgery - Tulsa

Trial Details

FieldValue
Enrollment Target 228 participants
Start Date 2003-10
Est. Completion 2011-06

Sponsor

University of Oklahoma

358 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00728650

The ClinicalTrials.gov registry entry for NCT00728650 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 228 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 445-participant average among 78 other Liver Cancer trials with a reported enrollment target (49% lower). The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Liver Cancer appearing as the primary indexed condition, and to 0 interventions.

NCT00728650 reports 1 study location spanning 1 distinct geographic area - top geographies include Oklahoma.

Frequently Asked Questions

What is clinical trial NCT00728650 about?

NCT00728650 is a clinical study titled "A Retrospective Review of Malignant Liver Tumors". This study will review the treatment and outcomes of patients having primary and metastatic hepatic malignancies. Patients treated with surgical resection, percutaneous radiofrequency ablation (RFA), and transarterial chemoembolization (TACE) will be compared with patients not receiving these treatm...

What is the current status of trial NCT00728650?

This trial is currently completed. The enrollment target is 228 participants. The study started on 2003-10. Estimated completion is 2011-06.

What conditions does trial NCT00728650 study?

This clinical trial studies the following conditions: Liver Cancer.

Who is sponsoring clinical trial NCT00728650?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00728650 being conducted?

This trial has 1 study location across Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Liver Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Liver Cancer

All registered trials for this condition

Oklahoma

All trials with a study site in Oklahoma

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.